Brivanib Placebo

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Hepatocellular CarcinomaMetastatic Colorectal Cancer (MCRC)

Phase 1

Phase I/II Combination With Irinotecan- Erbitux

CompletedNCT00594984

Bristol-Myers SquibbMetastatic Colorectal Cancer (MCRC)

Start: 2008-05-31End: 2012-12-31Updated: 2015-11-04

Phase 3

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

CompletedNCT00908752

Bristol-Myers SquibbHepatocellular Carcinoma

Start: 2009-07-20End: 2018-01-26Updated: 2019-12-02